These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12584776)

  • 21. Should employees be tested for immunity after hepatitis B vaccination?
    J Occup Med; 1993 Nov; 35(11):1081-2. PubMed ID: 8295028
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Q: Do patients who received only two doses of hepatitis B vaccine need a booster?
    Junewicz A; Brateanu A; Nielsen C
    Cleve Clin J Med; 2014 Jun; 81(6):346-8. PubMed ID: 24891535
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals.
    Da Villa G; Romanò L; Sepe A; Iorio R; Paribello N; Zappa A; Zanetti AR
    Vaccine; 2007 Apr; 25(16):3133-6. PubMed ID: 17280750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody decline after hepatitis B vaccination and the effects of boosters.
    Aspinall S; Kocks DJ
    S Afr Med J; 1995 Apr; 85(4):283-4. PubMed ID: 7778007
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later.
    Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Massé R; Duval B
    Vaccine; 2009 Oct; 27(43):6048-53. PubMed ID: 19683086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful use of Fendrix in HIV-infected non-responders to standard hepatitis B vaccines.
    de Silva TI; Green ST; Cole J; Stone BJ; Dockrell DH; Vedio AB
    J Infect; 2014 Apr; 68(4):397-9. PubMed ID: 24384506
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of a preschool booster for children born to hepatitis B-positive mothers.
    Ladhani SN; Ramsay ME
    Arch Dis Child; 2013 Jun; 98(6):395-6. PubMed ID: 23625988
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term protection of hepatitis B vaccine 18 years after vaccination.
    Alfaleh F; Alshehri S; Alansari S; Aljeffri M; Almazrou Y; Shaffi A; Abdo AA
    J Infect; 2008 Nov; 57(5):404-9. PubMed ID: 18829116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk factors of and mechanism for non-responsiveness to hepatitis B vaccination].
    Zhuang GH; Yan H; Wang XL
    Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):157-60. PubMed ID: 16494797
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of circadian rhythm on the efficacy of the hepatitis B vaccination.
    Karabay O; Temel A; Koker AG; Tokel M; Ceyhan M; Kocoglu E
    Vaccine; 2008 Feb; 26(9):1143-4. PubMed ID: 18255201
    [No Abstract]   [Full Text] [Related]  

  • 35. Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination.
    Papaevangelou V; Hadjichristodoulou C; Cassimos DC; Pantelaki K; Tzivaras A; Hatzimichael A; Theodoridou M
    Infection; 2008 Mar; 36(2):135-9. PubMed ID: 18231718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines.
    Zuckerman JN
    J Med Virol; 2006 Feb; 78(2):169-77. PubMed ID: 16372285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants.
    Fitzsimons D; François G; Hall A; McMahon B; Meheus A; Zanetti A; Duval B; Jilg W; Böcher WO; Lu SN; Akarca U; Lavanchy D; Goldstein S; Banatvala J; Damme PV
    Vaccine; 2005 Jul; 23(32):4158-66. PubMed ID: 15964484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatitis B immunization for newborn infants of hepatitis B surface antigen-positive mothers].
    Cowan SA; Qureshi KM
    Ugeskr Laeger; 2007 Oct; 169(41):3471-4. PubMed ID: 17967274
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody titers and response to vaccination against hepatitis A and B in pediatric patients with portal hypertension.
    Rosa MN; Hessel G; Alves De Tommaso AM
    Acta Gastroenterol Latinoam; 2008 Sep; 38(3):187-93. PubMed ID: 18979898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.